Skip to main content

Day: November 17, 2023

ACV Panels Discuss using AI for Trusted Vehicle Valuation and Disposal Strategies at Used Car Week 2023

The leading digital automotive marketplace shares insights following executive panel participation and exhibiting at the event. BUFFALO, N.Y., Nov. 17, 2023 (GLOBE NEWSWIRE) — ACV (Nasdaq: ACVA), the leading digital automotive marketplace and data services partner for dealers and commercial clients, just returned from another year as a platinum-level sponsor and exhibitor at Used Car Week 2023, which took place in Scottsdale, Arizona, from November 6-9. This annual conference united all corners of the used-car industry and facilitated conversations with dealers on the showroom floor that provided invaluable insights and learnings. During the event, several ACV executives shared their insights on the overall industry, as well as the company’s ongoing work to enhance its AI-based offerings and capabilities for its dealer and commercial...

Continue reading

Aquafil Announces Main Goals and Financial Targets Presentation

Management Presentation to be webcast live on November 21, 2023 at 2:30PM CET/8:30AM Eastern Standard Time ARCO, Italy, Nov. 17, 2023 (GLOBE NEWSWIRE) — Aquafil SpA (ECNLF:OTCQX – ECNL:IM), based in Arco (TN) Italy, pioneer of circular economy, today announced that it will be hosting a Presentation, “Main Goals & Financial Targets 2023 – 2025,” on November 21, 2023, at 8:30 am Eastern Standard Time. The event will take place live at Palazzo Giureconsulti – Piazza dei Mercanti, 2, 20123 Milan. For those unable to attend, the Presentation is being webcast. You can register to receive the link for the connection by completing this form or access the presentation in a listen/watch only mode on YouTube. A replay will be available after the end of the Presentation through November 28, 2023. The replay can be accessed...

Continue reading

Form 8.3 – Young & Co.’s Brewery – 16 11 2023 – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Young & Co.’s Brewery plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Change of Board of Directors – employee elected member steps down and is succeeded by alternate

Company Announcement Copenhagen, 17 November 2023 No. 29/2023 Change of Board of Directors – employee elected member steps down and is succeeded by alternate ISS A/S, a leading workplace experience and facility management company, today announces that Kadir Ünver is stepping down as an employee elected member of the Board of Directors of ISS A/S as of 20 November 2023. “I would like to thank Kadir Ünver for his time and contribution as a member of the board,” says Niels Smedegaard, Chair of the Board of Directors. For the remaining part of the term, Kadir Ünver will be succeeded by the alternate Rune Christensen, who is Head of Legal Affairs & M&A Support. For investor enquiries Jacob Johansen, Head of Group Investor Relations, +45 21 69 35 91 Kristian Tankred, Senior Investor Relations Manager, +45 30 67 35 25 For media enquiries...

Continue reading

Aéroports de Paris S.A – October 2023 traffic figures

PRESS RELEASENovember 17th, 2023 Aéroports de Paris SA October 2023 traffic figures Unless otherwise indicated, the following changes are expressed in comparison with the same period in 2022.This press release supplements the October 2023 traffic release published on November 15. It includes the previously missing traffic data for TAV Airports and group traffic. Data for other airports remain unchanged. October 2023 traffic:Group traffic1: up +10.9%, to 30.3 million passengers, standing at 101.1% of 2019 traffic; Paris Aéroport’s traffic: up +8.3%, to 8.9 million passengers, standing at 96.0% of 2019 traffic.GROUP TRAFFIC    October 2023 January – October 2023Passengers Change 23/22 % of trafficvs. 2019 Passengers Change 23/22 % of trafficvs. 2019Paris-CDG 5,984,270 +10.5% 90.1% 56,824,839...

Continue reading

Form 8.3 – Young & Co.’s Brewery – 16 11 2023 – Opening Disclosure (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary Clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Young & Co.’s Brewery plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Form 8.3 – City Pub Group plc – 16 11 2023 – Opening Disclosure (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree City Pub Group plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Form 8.3 – City Pub Group plc – 16 11 2023 – Opening Disclosure (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree City Pub Group plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Uppsala University Hospital and Sana Biotechnology Announce Authorization of the First-in-Human Clinical Trial Application for a Primary Islet Cell Treatment for Patients with Type 1 Diabetes

Goal is to report UP421 proof of concept data in 2023 and 2024 Potential to remove immunosuppression from islet cell transplantation SEATTLE, Nov. 17, 2023 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, and Uppsala University Hospital in Sweden today announced the Swedish Medical Products Agency has authorized Uppsala University’s Clinical Trial Application (CTA) to initiate an investigator-sponsored, first-in-human study of UP421, an allogeneic, primary islet cell therapy engineered with Sana’s hypoimmune (HIP) technology, in patients with type 1 diabetes. The goal of UP421 treatment is to provide proof of concept for transplanting functional islet cells without immunosuppression. UP421 is engineered using Sana’s hypoimmune platform...

Continue reading

Sprout Social Names Scott Morris as Chief Marketing Officer

CHICAGO, Nov. 17, 2023 (GLOBE NEWSWIRE) — Sprout Social, Inc. (“Sprout Social”, the “Company”) (Nasdaq: SPT), an industry-leading provider of cloud-based social media management software, today announced the appointment of Scott Morris to chief marketing officer (CMO), effective December 4, 2023. As CMO, Morris will oversee Sprout’s global marketing organization and be a key contributor to Sprout’s continued growth. Morris brings more than 25 years of experience leading key strategic marketing initiatives at both B2B and B2C tech companies. Prior to Sprout, Morris held executive leadership positions at Zendesk including SVP Global Marketing and Acting CMO, during which time he led the company’s 400-person global marketing and communications team, and was responsible for building the Zendesk brand and partnering with Sales to deliver...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.